Significantly Refreshed Board Overseeing Successful Execution of Amarins Transformation Plan to Drive Short- and Long-Term Value; Outmatches Sarissas Slate in…
Marks 7th Regulatory Approval for VASCEPA®/VAZKEPA® Franchise in Key International Markets Since 2022 Marks 7th Regulatory Approval for VASCEPA®/VAZKEPA® Franchise…
-- Board Refreshment Process Has Been Comprehensive, Independent and Transparent; Sarissas Candidates Are Not Qualified Versus Recently Appointed Board Members…